Your browser doesn't support javascript.
loading
Complotype affects the extent of down-regulation by Factor I of the C3b feedback cycle in vitro.
Lay, E; Nutland, S; Smith, J E; Hiles, I; Smith, R A G; Seilly, D J; Buchberger, A; Schwaeble, W; Lachmann, P J.
Affiliation
  • Lay E; Department of Veterinary Medicine, University of Cambridge, UK.
  • Nutland S; Cambridge Bioresource, Cambridge University and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Smith JE; Immuno-inflammation Therapy Area, GlaxoSmithKline R&D, Stevenage, Hertfordshire, UK.
  • Hiles I; Biopharm-Discovery, GlaxoSmithKline R&D, Stevenage, Hertfordshire, UK.
  • Smith RA; Protein Therapeutics Laboratory, MRC Centre for Transplantation, King's College London, Guy's Hospital, London, UK.
  • Seilly DJ; Department of Veterinary Medicine, University of Cambridge, UK.
  • Buchberger A; Department of Infection, University of Leicester, Leicester, UK.
  • Schwaeble W; Department of Infection, University of Leicester, Leicester, UK.
  • Lachmann PJ; Department of Veterinary Medicine, University of Cambridge, UK.
Clin Exp Immunol ; 181(2): 314-22, 2015 Aug.
Article in En | MEDLINE | ID: mdl-25124117

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / Fibrinogen / Complement C3b / Gene Expression Regulation / Complement Pathway, Alternative Type of study: Prognostic_studies Limits: Humans Language: En Journal: Clin Exp Immunol Year: 2015 Type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / Fibrinogen / Complement C3b / Gene Expression Regulation / Complement Pathway, Alternative Type of study: Prognostic_studies Limits: Humans Language: En Journal: Clin Exp Immunol Year: 2015 Type: Article Affiliation country: United kingdom